About NRG GY018: Pembrolizumab Plus Chemotherapy in Endometrial CancerByJohn Nakayama, MDFebruary 11th 2024John Nakayama, MD, discusses the significance of the NRG GY018 study in endometrial cancer.
Discussing Recent Advances for Patients With Endometrial Cancer ByJohn Nakayama, MDMay 10th 2023John Nakayama, MD, discusses what the evolution of endometrial cancer treatment has looked like in recent years.